Lorlatinib/How much does a box of Lorlatinib cost in 2025?

Lorlatinib is mainly used for patients with ALK-positive non-small cell lung cancer, especially those who are resistant to first- or second-generation ALK inhibitors, or individuals with brain metastases. In the treatment plan, lorlatinib can maintain its efficacy for a long time through oral administration, inhibit tumor growth, delay disease progression, and at the same time improve the neurological function and quality of life of patients with brain metastases. Its pharmacological feature is that the third-generation ALK inhibitor has high blood-brain barrier penetration ability, providing an effective option for patients with previous drug resistance or brain metastasis. This is an advantage that early ALK inhibitors are difficult to achieve.

In China, the original drug of lorlatinib has been included in Class B medical insurance. Patients can obtain the drug through medical insurance reimbursement at designated hospitals or pharmacies, reducing their financial burden. Common specifications include90 tablets of 25mg and 30 tablets of 100mg. The price per box is about 20,000 yuan. Prices in overseas markets vary widely: original drugs in Hong Kong are usually priced at RMB 30,000 to RMB 50,000, while original drugs in Turkey are relatively cheap, about RMB 10,000. At the same time, there are also lower-priced generic drugs in overseas markets. For example, the 100mg*30-tablet generic drug produced by a Lao pharmaceutical factory sells for about 1,000 yuan. The ingredients of these drugs are basically the same as the original drugs, providing an alternative option for patients with limited financial ability.

In clinical practice, long-term maintenance treatment with lorlatinib needs to be combined with regular imaging evaluation and monitoring of hematological indicators, including blood lipids, liver function, heart rate and neurological symptoms. Through scientific management, we can control potential side effects while extending progression-free survival, and achieve safe and effective treatment. The coverage of medical insurance policies and diversified drug sources enable patients to obtain standardized treatment within an affordable and economical range, ensuring continuity of treatment and improving quality of life.

References：https://www.lorbrena.com/